Makoto Hashimoto
- Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments 70
- Neuroinflammation and Neurodegeneration Mechanisms 18
- Neurological disorders and treatments 16
- Neurological diseases and metabolism 7
- Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments 70
- Neuroinflammation and Neurodegeneration Mechanisms 18
- Neurological disorders and treatments 16
- Neurological diseases and metabolism 7
- Cellular and Molecular Neuroscience top 0.2%
- Nuclear Receptors and Signaling 31
- Nerve injury and regeneration 15
- Neuroscience and Neuropharmacology Research 9
- Biological Psychiatry top 1%
- Physiology top 0.5%
- Alzheimer's disease research and treatments 50
- Co-authors
- Eliezer MasliahEdward RockensteinMargaret MalloryTakato TakenouchiAyako TakedaMasayo FujitaYutaka SagaraIsaac Veinbergs
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (8 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Makoto Hashimoto
125 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Neurology 6.1k
- Neurology 2.2k
- Cellular and Molecular Neuroscience 3.8k
- Biological Psychiatry 353
- Physiology 3.6k
Countries citing papers authored by Makoto Hashimoto
This map shows the geographic impact of Makoto Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Hashimoto more than expected).
Fields of papers citing papers by Makoto Hashimoto
This network shows the impact of papers produced by Makoto Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Hashimoto. The network helps show where Makoto Hashimoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Makoto Hashimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 13 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 4 | |
| 5 | 2018 | 15 | |
| 6 | 2018 | 14 | |
| 7 | 2015 | 72 | |
| 8 | 2013 | 5 | |
| 9 | 2010 | 45 | |
| 10 | 2009 | 115 | |
| 11 | 2009 | 8 | |
| 12 | 2008 | 50 | |
| 13 | 2007 | 98 | |
| 14 | 2005 | 48 | |
| 15 | 2005 | 85 | |
| 16 | 2003 | 77 | |
| 17 | 2002 | 171 | |
| 18 | 2001 | 66 | |
| 19 | α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stressbreakdown → | 2000 | 570 |
| 20 | 1998 | 154 |
About Makoto Hashimoto
Makoto Hashimoto is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 126 papers that have together received 9.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (70 papers), Alzheimer's disease research and treatments (50 papers), Nuclear Receptors and Signaling (31 papers), Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Neurological disorders and treatments (16 papers), Nerve injury and regeneration (15 papers), Neuroscience and Neuropharmacology Research (9 papers) and Neurological diseases and metabolism (7 papers). The work is most often cited by research in Neurology (6.1k citations), Neurology (2.2k citations) and Cellular and Molecular Neuroscience (3.8k citations). Makoto Hashimoto has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Eliezer Masliah, Edward Rockenstein, Margaret Mallory, Takato Takenouchi, Ayako Takeda, Masayo Fujita, Yutaka Sagara, Isaac Veinbergs, Shuei Sugama and Leigh J. Hsu. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.